These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36195617)

  • 1. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome MJ; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Subramoney K; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Nat Commun; 2022 Oct; 13(1):5860. PubMed ID: 36195617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Wolter N; Jassat W; Walaza S; Welch R; Moultrie H; Groome M; Amoako DG; Everatt J; Bhiman JN; Scheepers C; Tebeila N; Chiwandire N; du Plessis M; Govender N; Ismail A; Glass A; Mlisana K; Stevens W; Treurnicht FK; Makatini Z; Hsiao NY; Parboosing R; Wadula J; Hussey H; Davies MA; Boulle A; von Gottberg A; Cohen C
    Lancet; 2022 Jan; 399(10323):437-446. PubMed ID: 35065011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
    Tegally H; Moir M; Everatt J; Giovanetti M; Scheepers C; Wilkinson E; Subramoney K; Makatini Z; Moyo S; Amoako DG; Baxter C; Althaus CL; Anyaneji UJ; Kekana D; Viana R; Giandhari J; Lessells RJ; Maponga T; Maruapula D; Choga W; Matshaba M; Mbulawa MB; Msomi N; ; Naidoo Y; Pillay S; Sanko TJ; San JE; Scott L; Singh L; Magini NA; Smith-Lawrence P; Stevens W; Dor G; Tshiabuila D; Wolter N; Preiser W; Treurnicht FK; Venter M; Chiloane G; McIntyre C; O'Toole A; Ruis C; Peacock TP; Roemer C; Kosakovsky Pond SL; Williamson C; Pybus OG; Bhiman JN; Glass A; Martin DP; Jackson B; Rambaut A; Laguda-Akingba O; Gaseitsiwe S; von Gottberg A; de Oliveira T
    Nat Med; 2022 Sep; 28(9):1785-1790. PubMed ID: 35760080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022.
    Sievers C; Zacher B; Ullrich A; Huska M; Fuchs S; Buda S; Haas W; Diercke M; An der Heiden M; Kröger S
    Euro Surveill; 2022 Jun; 27(22):. PubMed ID: 35656831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1-BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa.
    Johnson R; Mangwana N; Sharma JR; Muller CJF; Malemela K; Mashau F; Dias S; Ramharack P; Kinnear C; Glanzmann B; Viraragavan A; Louw J; Surujlal-Naicker S; Nkambule S; Webster C; Mdhluli M; Gray G; Mathee A; Preiser W; Vorster A; Dalvie S; Street R
    J Infect Dis; 2022 Oct; 226(8):1418-1427. PubMed ID: 36017801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa.
    Jassat W; Abdool Karim SS; Ozougwu L; Welch R; Mudara C; Masha M; Rousseau P; Wolmarans M; Selikow A; Govender N; Walaza S; von Gottberg A; Wolter N; Terrence Pisa P; Sanne I; Govender S; Blumberg L; Cohen C; Groome MJ;
    Clin Infect Dis; 2023 Apr; 76(8):1468-1475. PubMed ID: 36453094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022.
    Bishop K; Meiring S; Tempia S; von Gottberg A; Wolter N; Kleynhans J; Moosa F; du Plessis M; Moyes J; Makhasi M; Chuene B; Samuels AM; Dawood H; Reubenson G; Zar HJ; Quan V; Cohen C; Walaza S
    Influenza Other Respir Viruses; 2024 May; 18(5):e13300. PubMed ID: 38666359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
    Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Casado I; Navascués A; Burgui C; Ezpeleta C; Castilla J; Guevara M; ;
    Euro Surveill; 2023 Feb; 28(5):. PubMed ID: 36729113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
    Davies MA; Morden E; Rousseau P; Arendse J; Bam JL; Boloko L; Cloete K; Cohen C; Chetty N; Dane P; Heekes A; Hsiao NY; Hunter M; Hussey H; Jacobs T; Jassat W; Kariem S; Kassanjee R; Laenen I; Roux SL; Lessells R; Mahomed H; Maughan D; Meintjes G; Mendelson M; Mnguni A; Moodley M; Murie K; Naude J; Ntusi NAB; Paleker M; Parker A; Pienaar D; Preiser W; Prozesky H; Raubenheimer P; Rossouw L; Schrueder N; Smith B; Smith M; Solomon W; Symons G; Taljaard J; Wasserman S; Wilkinson RJ; Wolmarans M; Wolter N; Boulle A
    Int J Infect Dis; 2023 Feb; 127():63-68. PubMed ID: 36436752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa.
    Sun K; Tempia S; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; Carrim M; Martinson NA; Kahn K; Lebina L; du Toit JD; Mkhencele T; Viboud C; Cohen C;
    Nat Commun; 2023 Jan; 14(1):246. PubMed ID: 36646700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.
    Sarkar A; Omar S; Alshareef A; Fanous K; Sarker S; Alroobi H; Zamir F; Yousef M; Zakaria D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2212568. PubMed ID: 37254497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Low Incidence of Severe and Fatal COVID-19 Following Widespread Infection Induced Immunity after the Omicron (BA.1) Dominant in Gauteng, South Africa: An Observational Study.
    Madhi SA; Kwatra G; Myers JE; Jassat W; Dhar N; Mukendi CK; Blumberg L; Welch R; Izu A; Mutevedzi PC
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients.
    Teyssou E; Marot S; Cocherie T; Fauchois A; Abdi B; Todesco E; Akhavan S; Pourcher V; Calvez V; Marcelin AG; Soulie C
    Infect Dis Now; 2023 Feb; 53(1):104629. PubMed ID: 36323397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome.
    Lewnard JA; Hong V; Kim JS; Shaw SF; Lewin B; Takhar H; Tartof SY
    Nat Commun; 2023 Mar; 14(1):1407. PubMed ID: 36918548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.
    Relan P; Motaze NV; Kothari K; Askie L; Le Polain O; Van Kerkhove MD; Diaz J; Tirupakuzhi Vijayaraghavan BK
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37419502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
    Trobajo-Sanmartín C; Miqueleiz A; Guevara M; Fernández-Huerta M; Burgui C; Casado I; Baigorria F; Navascués A; Ezpeleta C; Castilla J
    J Infect Dis; 2023 Feb; 227(3):332-338. PubMed ID: 36179126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in England.
    Webster HH; Nyberg T; Sinnathamby MA; Aziz NA; Ferguson N; Seghezzo G; Blomquist PB; Bridgen J; Chand M; Groves N; Myers R; Hope R; Ashano E; Lopez-Bernal J; De Angelis D; Dabrera G; Presanis AM; Thelwall S
    Nat Commun; 2022 Oct; 13(1):6053. PubMed ID: 36229438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.